Civil society challenges WIPO over so-called Africa IP Summit

The Africa IP Summit is a highly controversial event, scheduled to be held in Cape Town in April, co-organised by World Intellectual Property Organisation (WIPO), the US Department of Commerce and a number of large US corporations (Microsoft, Eli Lilly. Pfizer, etc).

There are clear intentions to use this platform to promote for TRIPS-plus measures in intellectual property protection and enforcement in the African region. Needless to say that WIPO is also quite active on 'anti-counterfeit' initiatives; deliberately conflating questions of IPRs with questions about quality, safety and efficacy. The objectives of this 'summit' run counter to the spirit and the letter of the Development Agenda adopted by WIPO in 2007.

PHM has joined 99 NGOs and academics urging WIPO to reconsider.

Please read, circulate, publicise and write directly to WIPO. 

Download Individual Chapters of GHW-3

Global Health Watch 3 was launched on 19 October 2011 in Rio de Janeiro, Brazil.  View the power point presentation, providing an overview of the contents of GHW-3, here.


Section I: The Global Political and Economic Architecture

A.1. Economic Crisis and Systemic Failure: Why we need to rethink the global economy

For First Time, Unicef Reveals Differences in Prices it Pays Drug Companies for Vaccines

Published: May 27, 2011

The United Nations Children’s Fund on Friday publicly listed for the first time the price it pays for vaccines.

The decision — which immediately revealed wide disparities in what vaccine makers charge — could lead to drastic cuts in prices for vaccines that save millions of children’s lives.

Unicef paid $747 million for vaccines last year, buying over two billion doses for 58 percent of the world’s children.

PHM Statement at the 64th WHA on Future Financing of WHO


Are donors and not its mandate controlling WHO?


More than 80% of WHO's funding today is through tied projects or programs. Is this dictating the policies of WHO to the detriment of its original vision of public health? Professor David Legge discusses these issues with Newsclick.

MDGs: A critique


Interview with Claudio Schuftan: A list of essays on public health, nutrition and human rights. Web:

Schuftan C. The MDGs: who for, and what for?

World Public Health Nutrition Association - Column 9-10 by Claudio Schuftan

Influence of Malthus

 Tristram Hunt explores how the ideas of the 18th-century British economist Robert Malthus wrought havoc in 19th-century India, yet were later adopted by Indians themselves.
Listen to the audio:

In this new series for BBC Radio 3, historian Tristram Hunt rediscovers the stories of three ideas that emerged in Britain - and then traces how their impact has spread far beyond our shores.

Statement by PHM to Executive Board of WHO, 20 Jan, 2011

The future of financing for WHO

Statement by People's Health Movement (PHM) to Executive Board of WHO, 20 Jan, 2011

WHO faces a financial crisis. The increasing dependence on extra‐budgetary funds relative to assessed contributions is distorting priority setting. Allocations to the social determinants of health have shrunk while expenditures on medicines are growing although funding to promote the rational use of medicines has almost dried up entirely.

PHM letter to the members of the Executive Board of WHO Jan 2011

Issues for consideration at the WHO Executive Board

Distinguished members of the Executive Board of WHO,

On behalf of the People’s Health Movement and a number of affiliated networks I submit the comments and suggestions included below regarding some of the items appearing on the agenda of the WHO Executive Board. We hope that you may find time to read and consider these comments before the relevant discussions at the EB. We hope that you find them useful.

MSF: Ten Stories That Mattered in Access to Medicines in 2010

Among the positive stories of 2010 - two crucial new medical tools could benefit people in developing countries:  a new vaccine could prevent the worst meningitis epidemics in Africa if there is political will to vaccinate broadly in all 25 affected countries, and a new test for tuberculosis could improve diagnosis, while reducing the time it takes to detect drug-resistant forms of the disease from nearly three months to less than two hours.